• University of East Anglia Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • National University of Singapore Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • London School of Economics and Political Science Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
  • Peter MacCallum Cancer Centre Featured PhD Programmes

Postgrad LIVE! Study Fair

Birmingham | Bristol | Sheffield | Liverpool | Edinburgh

University of Edinburgh Featured PhD Programmes
University of Kent Featured PhD Programmes
Coventry University Featured PhD Programmes
University College London Featured PhD Programmes
University College London Featured PhD Programmes

Investigating the use of heat stable bacterial spores as novel mucosal vaccines

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

Heat stable bacterial spores are being used as novel mucosal vaccines. Spores of Bacillus subtilis have been used successfully as both vaccines and adjuvants against a number of diseases. They can be engineered to express antigens or alternatively coated with antigen. Both live and killed spores can be used. Spore vaccines promote balanced Th1/Th2 immune responses and in the MALT promote high levels of secretory IgA. We are currently working on a number of vaccines including Clostridium difficile, influenza and TB. We work with a number of pharma companies with both human and veterinary vaccine projects. The project would incorporate one or more aspects of the spore vaccine technology and would involve microbiology, genetic engineering, molecular biology, animal studies, cell culture and immunology. Thus, the project assigned would lead to the acquisition of a number of important skill-sets.

References

Huang, J.M., Hong, H.A., Van Tong, H., Hoang, T.H., Brisson, A., Cutting, S.M., 2010. Mucosal delivery of antigens using adsorption to bacterial spores. Vaccine 28, 1021-1030.
Permpoonpattana, P., Hong, H.A., Khaneja, R., Cutting, S.M., 2012. Evaluation of Bacillus subtilis strains as probiotics and their potential as a food ingredient. Benef Microbes 3, 127-135.
Permpoonpattana, P., Hong, H.A., Phetcharaburanin, J., Huang, J.M., Cook, J., Fairweather, N.F., Cutting, S.M., 2011. Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B. Infection and immunity 79, 2295-2302.
Song, M., Hong, H.A., Huang, J.M., Colenutt, C., Khang, D.D., Nguyen, T.V., Park, S.M., Shim, B.S., Song, H.H., Cheon, I.S., Jang, J.E., Choi, J.A., Choi, Y.K., Stadler, K., Cutting, S.M., 2012. Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. Vaccine 30, 3266-3277

How good is research at Royal Holloway, University of London in Biological Sciences?

FTE Category A staff submitted: 24.00

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully




Cookie Policy    X